VYST

Vystar Corp
2 filings tracked
healthcaremedical devicesMICRO (<$300M)

Signal Magnitude Chart

BEARISH | 90% | 5/13/2026 | earnings missBULLISH | 70% | 5/13/2026 | acquisitionBULLISH | 50% | 5/13/2026 | margin expansionBEARISH | 80% | 5/13/2026 | dilution riskBEARISH | 90% | 5/13/2026 | earnings missBULLISH | 70% | 5/13/2026 | acquisitionBULLISH | 50% | 5/13/2026 | margin expansionBEARISH | 80% | 5/13/2026 | dilution riskMay 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

bearishMay 13

Revenue collapsed 51.4% year-over-year to $6,147.

earnings miss
90%
bullishMay 13

Binding LOI to acquire 50% of Capital R3alm, Inc. for Web3 expansion.

acquisition
70%
bullishMay 13

Gross profit remained stable despite revenue plunge due to 77.5% drop in cost of revenues.

margin expansion
50%
bearishMay 13

Issuance of Series B preferred shares for R3alm acquisition will dilute existing equity.

dilution risk
80%
bearishMay 13

Revenue collapsed 51.4% year-over-year to $6,147.

earnings miss
90%
bullishMay 13

Binding LOI to acquire 50% of Capital R3alm, Inc. for Web3 expansion.

acquisition
70%
bullishMay 13

Gross profit remained stable despite revenue plunge due to 77.5% drop in cost of revenues.

margin expansion
50%
bearishMay 13

Issuance of Series B preferred shares for R3alm acquisition will dilute existing equity.

dilution risk
80%